Cancer, Venous Thromboembolism
Conditions
Brief summary
To determine the efficacy and to measure the complications of prophylactic anticoagulation using low-molecular weight heparin in adult cancer patients under palliative care
Interventions
DRUGnadroparin
Sponsors
University Hospital, Geneva
Study design
Observational model
DEFINED_POPULATION
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
0 Years to No maximum
Inclusion criteria
* Cancer patients in palliative care * Patients fully informed about their condition * Signed informed consent * No
Countries
Switzerland
Outcome results
None listed